|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:278-285
© 2009 The American Association for Thoracic Surgery
Point/Counterpoint |
Department of Cardiac Surgery, University of Palermo, Palermo, Italy
Received for publication May 2, 2008; revisions received September 29, 2008; accepted for publication November 7, 2008. * Address for reprints: Khalil Fattouch, MD, PhD, University of Palermo, Department of Cardiac Surgery, Via Liborio Giuffré, 5, 90127 Palermo, Italy. (Email: khalilfattouch{at}hotmail.com).
Objective: Surgical management of moderate chronic ischemic mitral valve regurgitation is still debated. The aim of this study was to evaluate the effect of adding mitral valve repair to coronary artery bypass grafting on clinical outcomes and left ventricular remodeling in patients who underwent coronary artery bypass grafting alone versus coronary artery bypass grafting plus mitral valve repair in a randomized trial.
Methods: Between February 2003 and May 2007, 102 patients were eligible for this study and were randomly assigned to one of 2 groups by means of card allocation: coronary artery bypass grafting plus mitral valve repair (CABG plus MVR group; 48 patients, 47%) or coronary artery bypass grafting alone (CABG group; 54 patients, 53%). The 2 groups were similar regarding demographics, perioperative clinical data, and outcomes. There were differences regarding cardiopulmonary bypass (P < .0001) and aortic crossclamp (P < .0001) times. Exercise tests were performed for all survivors to evaluate tolerance to exercise and variability on grade of mitral regurgitation and systolic pulmonary arterial pressure. The study was blinded for physicians and nurses involved in postoperative care and clinical follow-up. The mean follow-up was 32 ± 18 months.
Results: Overall in-hospital mortality was 3% (3 patients). One (1.8%) patient died in the CABG group, and 2 (4.1%) patients died in the CABG plus MVR group. Survival rates ± standard error at 5 years for patients in the CABG and CABG plus MVR groups were 88.8% ± 3.2% and 93.7% ± 3.1%, respectively. A significant difference was found between the 2 groups with regard to mean New York Heart Association class (P < .0001), left ventricular end-diastolic diameter (P < .01), left ventricular end-systolic diameter (P < .01), pulmonary arterial pressure (P < .0001), and left atrial size (P < .01). At follow-up, coronary artery bypass grafting alone was able to reduce mitral regurgitation grade in 40% of patients, whereas in the remaining patients mitral regurgitation grade remained stable or worsened. In the CABG group, among the 17 patients with mild mitral regurgitation and 12 patients with moderate mitral regurgitation at rest, 7 (40%) and 9 (75%) patients, respectively, had worsening in mitral regurgitation grade and pulmonary artery pressure during exercise.
Conclusions: The efficacy of adding mitral valve repair to coronary artery bypass grafting is well demonstrated by the improvement of New York Heart Association functional class and percentage of left ventricular ejection fraction and by the decrease of mitral regurgitation grade, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, pulmonary artery pressure, and left atrial size. Moreover, coronary artery bypass grafting alone left more patients with heart failure symptoms at rest and during exercise. Combined coronary artery bypass grafting and mitral valve repair have no effect on survival at short-term follow-up, and the trends that are evident will likely become more significant with time.
This article has been cited by other articles:
![]() |
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 4 - 34. [Full Text] [PDF] |
||||
![]() |
P. K. Smith, R. E. Michler, Y. J. Woo, J. H. Alexander, J. D. Puskas, M. K. Parides, R. T. Hahn, J. B. Williams, J. M. Dent, T. B. Ferguson Jr., et al. Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network J. Thorac. Cardiovasc. Surg., January 1, 2012; 143(1): 111 - 117.e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al. Special Article: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Anesth. Analg., January 1, 2012; 114(1): 11 - 45. [Full Text] [PDF] |
||||
![]() |
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2584 - 2614. [Full Text] [PDF] |
||||
![]() |
L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, A. M. Hutter Jr, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 6, 2011; 58(24): e123 - e210. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, December 6, 2011; 124(23): e652 - e735. [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, L. D. Hillis, P. K. Smith, J. L. Anderson, J. A. Bittl, C. R. Bridges, J. G. Byrne, J. E. Cigarroa, V. J. DiSesa, L. F. Hiratzka, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation, December 6, 2011; 124(23): 2610 - 2642. [Full Text] [PDF] |
||||
![]() |
S. Kainuma, K. Taniguchi, K. Toda, T. Funatsu, H. Kondoh, M. Nishino, T. Daimon, and Y. Sawa Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation J. Thorac. Cardiovasc. Surg., October 1, 2011; 142(4): 783 - 792. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Acker, M. Jessup, S. F. Bolling, J. Oh, R. C. Starling, D. L. Mann, H. N. Sabbah, R. Shemin, J. Kirklin, and S. H. Kubo Mitral valve repair in heart failure: Five-year follow-up from the mitral valve replacement stratum of the Acorn randomized trial J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 569 - 574.e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Calafiore, A. L. Iaco, A. Bivona, E. Varone, S. Scandura, P. Greco, A. Romeo, and M. Di Mauro Echocardiographically based treatment of chronic ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., May 1, 2011; 141(5): 1150 - 1156.e1. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Pierard and B. A. Carabello Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment Eur. Heart J., December 2, 2010; 31(24): 2996 - 3005. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, H. F. Verwey, J. J. Bax, V. Delgado, E. R. Holman, M. J. Schalij, E. E. van der Wall, J. Braun, et al. Clinical and Functional Effects of Restrictive Mitral Annuloplasty at Midterm Follow-Up in Heart Failure Patients Ann. Thorac. Surg., December 1, 2010; 90(6): 1913 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Glower Invited Commentary Ann. Thorac. Surg., December 1, 2010; 90(6): 1920 - 1921. [Full Text] [PDF] |
||||
![]() |
E. A. ten Brinke, R. J. Klautz, S. A. Tulner, H. F. Verwey, J. J. Bax, M. J. Schalij, E. E. van der Wall, M. I. Versteegh, R. A. Dion, and P. Steendijk Long-term effects of surgical ventricular restoration with additional restrictive mitral annuloplasty and/or coronary artery bypass grafting on left ventricular function: Six-month follow-up by pressure-volume loops J. Thorac. Cardiovasc. Surg., December 1, 2010; 140(6): 1338 - 1344. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fattouch, R. Sampognaro, G. Speziale, M. Salardino, G. Novo, M. Caruso, S. Novo, and G. Ruvolo Impact of Moderate Ischemic Mitral Regurgitation After Isolated Coronary Artery Bypass Grafting Ann. Thorac. Surg., October 1, 2010; 90(4): 1187 - 1194. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pocar, D. Passolunghi, A. Moneta, A. Di Mauro, A. Bregasi, R. Mattioli, and F. Donatelli Baseline left ventricular function and surgical annular stiffening to predict outcome and reverse left ventricular remodeling after undersized annuloplasty for intermediate-degree ischemic mitral regurgitation J. Thorac. Cardiovasc. Surg., June 1, 2010; 139(6): 1529 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pocar, A. Di Mauro, D. Passolunghi, A. Moneta, A. M. T. A. Alsheraei, A. Bregasi, R. Mattioli, and F. Donatelli Predictors of adverse events after surgical ventricular restoration for advanced ischaemic cardiomyopathy Eur J Cardiothorac Surg, May 1, 2010; 37(5): 1093 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gardner and P. T. O'Gara The Cardiothoracic Surgery Network: Randomized clinical trials in the operating room. J. Thorac. Cardiovasc. Surg., April 1, 2010; 139(4): 830 - 834. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |